Summary
In order to determine the relevance of 5-HT1A-related signal transduction in the mode of action of lithium and antidepressants, the effects of long-term treatment with these drugs on the 5-HT1A-mediated inhibition of forskolin-stimulated adenylate cyclase activity were investigated in the rat hippocampal membranes. Chronic administration of antidepressants altered neither the [3H]8-hydroxy-2-(di-n-propylamino)tetralin ([3H]8-OH-DPAT) binding sites nor the inhibition of forskolin-stimulated adenylate cyclase activity by 5-HT. Long-term treatment with lithium did not affect the inhibitory effect of 5-HT on the forskolin-stimulated adenylate cyclase activity, either. Neither the stimulation by forskolin nor the inhibition by guanyl-5′-ylimidodiphosphate (Gpp(NH)p) of adenylate cyclase activity was not influenced by lithium treatment, suggesting that lithium has no effects on the components of adenylate cyclase system distal to the 5-HT1A receptors.
These results indicate that the 5-HT1A-mediated neural transmission has not such an important relevance in the mechanisms of action of lithium or antidepressants.
Similar content being viewed by others
References
Amsterdam JD, Berwish N, Potter L, Rickels K (1987) Open trial of gepirone in the treatment of major depressive disorder. Curr Ther Res 41: 185–193
Andree TH, Mikuni M, Tong CY, Koenig JI, Meltzer HY (1986) Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex. J Neurochem 46: 191–197
Avissar S, Schreiber G, Danon A, Belmaker RH (1988) Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature 331: 440–442
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25: 563–576
De Vivo M, Maayani S (1986) Characterization of the 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J Pharmacol Exp Ther 238: 248–253
De Vivo M, Maayani S (1990) Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors. Biochem Pharmacol 40: 1551–1558
Goodwin GM (1989) The effects of antidepressant treatments and lithium upon 5-HT1A receptor function. Prog Neuropsychopharmacol Biol Psychiatry 13: 445–451
Goodwin FK, Post RM (1983) 5-Hydroxytryptamine and depression: a model for the interaction of normal variance with pathology. Br J Clin Pharmacol 15: 393S-405S
Harrington MA, Oksenberg D, Peroutka SJ (1988) 5-Hydroxytryptamine1A receptors are linked to a Gi-adenylate cyclase complex in rat hippocampus. Eur J Pharmacol 154: 95–98
Hotta I, Yamawaki S, Segawa T (1986) Long-term lithium treatment causes serotonin receptor down-regulation via serotonergic presynapses in rat brain. Neuropsycho-biology 16: 19–26
Katada T, Oinuma M, Ui M (1986) Two guanine nucleotide-binding proteins in rat brain serving as the specific substrate of islet-activating protein, pertussis toxin. J Biol Chem 261: 8182–8191
Kellar KJ, Cascio CS, Butler JA, Kurtzke RN (1981) Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur J Pharmacol 69: 515–518
Kennett GA, Dourish CT, Curzon G (1987) Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in animal model of depression. Eur J Pharmacol 134: 265–274
Maggi A, Enna SJ (1980) Regional alterations in rat brain neurotransmitter systems fol-lowing chronic lithium treatment. J Neurochem 34: 888–892
Markstein R, Hoyer D, Engel G (1986) 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn-Schmiedebergs Arch Pharmacol 333: 335–341
Mizuta T, Segawa T (1988) Chronic effects of imipramine and lithium on postsynaptic 5-HT1Aand 5-HT1B sites and on presynaptic 5-HT3 sites in rat brain. Jpn J Pharmacol 47: 107–113
Mizuta T, Segawa T (1989) Chronic effects of imipramine and lithium on 5-HT receptor subtypes in rat frontal cortex, hippocampus and choroid plexus: quantitative receptor autoradiographic analysis. Jpn J Pharmacol 50: 315–326
Mørk A, Geisler A (1989) Effects of lithium ex vivo on the GTP-mediated inhibition of calcium-stimulated adenylate cyclase activity in rat brain. Eur J Pharmacol 168: 347–354
Newman ME, Lerer B (1988) Chronic electroconvulsive shock and desipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes. Eur J Pharmacol 148: 257–260
Newman ME, Drummer D, Lerer B (1990) Single and combined effects of desipramine and lithium on serotonergic receptor number and second messenger function in rat brain. J Pharmacol Exp Ther 252: 826–831
Odagaki Y, Koyama T, Matsubara S, Matsubara R, Yamashita I (1990) Effects of chronic lithium treatment on serotonin binding sites in rat brain. J Psychiatr Res 24: 271–277
Odagaki Y, Koyama T, Matsubara S, Yamashita I (1991 a) Effects of lithium on β-adrenergic receptor-adenylate cyclase system in rat cerebral cortical membranes. Jpn J Pharmacol 55: 407–414
Odagaki Y, Koyama T, Yamashita I (1991 b) Effects of long-term treatment with lithium and antidepressants on [3H]forskolin binding to rat cerebral cortical membranes. Prog Neuropsychopharmacol Biol Psychiatry (in press)
Peroutka SJ (1986) Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex. J Neurochem 47: 529–540
Peroutka SJ (1988) 5-Hydroxytryptamine receptor subtypes. Ann Rev Neurosci 11: 45–60
Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210: 88–90
Price LH, Charney DS, Delgado PL, Heninger GR (1990) Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology 100: 3–12
Schweizer EE, Amsterdam J, Rickels K, Kaplan M, Droba M (1986) Open trial of buspirone in the treatment of major depressive disorder. Psychopharmacol Bull 22: 183–185
Shenker A, Maayani S, Weinstein H, Green JP (1987) Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes. Mol Pharmacol 31: 357–367
Sleight AJ, Marsden CA, Palfreyman MG, Mir AK, Lovenberg W (1988) Chronic MAO A and MAO B inhibition decreases the 5-HT1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase. Eur J Pharmacol 154: 255–261
Tanimoto K, Maeda K, Terada T (1983) Inhibitory effect of lithium on neuroleptic and serotonin receptors in rat brain. Brain Res 265: 148–151
Treiser SL, Cascio CS, O'Donohue TL, Thoa NB, Jacobowitz DM, Kellar KJ (1981) Lithium increases serotonin release and decreases serotonin receptors in the hippo-campus. Science 213: 1529–1531
Willner P (1985) Antidepressants and serotonergic neurotransmission: an integrative review. Psychopharmacology 85: 387–404
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Odagaki, Y., Koyama, T. & Yamashita, I. No alterations in the 5-HT1A-mediated inhibition of forskolin-stimulated adenylate cyclase activity in the hippocampal membranes from rats chronically treated with lithium or antidepressants. J. Neural Transmission 86, 85–96 (1991). https://doi.org/10.1007/BF01250570
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01250570